Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 26, 2016 08:30 ET | Source: Medgenics, Inc.

Medgenics to Participate in the 2016 Canaccord Genuity Rare Disease, BioPharma One-On-One Day

PHILADELPHIA, Jan. 26, 2016 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), today announced that members of its management team will participate in the 2016 Canaccord Genuity Rare Disease,...
January 06, 2016 08:00 ET | Source: Medgenics, Inc.

Medgenics Licenses Novel GeneRide Gene Therapy Technology From Stanford University

PHILADELPHIA, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE:MDGN), today announced the signing of a license with Stanford University providing exclusive rights to certain breakthrough gene...
December 22, 2015 08:30 ET | Source: Medgenics, Inc.

Medgenics Announces Annual Renewal of Rare and Orphan Disease Research Collaboration With The Children’s Hospital of Philadelphia

Annual option exercised to extend collaboration First development candidate advancing to Phase 2/3 development in 2016Additional programs expected in 2016 PHILADELPHIA, Dec. 22, 2015 (GLOBE...
December 16, 2015 08:00 ET | Source: Medgenics, Inc.

Medgenics Announces Beta Thalassemia Research Program

PHILADELPHIA, Dec. 16, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), today announced the initiation of a research program to evaluate the use of TARGTEPOTM alone or in combination with...
November 25, 2015 08:30 ET | Source: Medgenics, Inc.

Medgenics to Present at 27th Annual Piper Jaffray Healthcare Conference

PHILADELPHIA, Nov. 25, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), today announced that Michael Cola, President and CEO, will participate in a fireside chat discussion at the 27th Annual...
October 22, 2015 08:00 ET | Source: Medgenics, Inc.

Medgenics Reports Third Quarter 2015 Financial Results

Acquired Phase 2-Ready CNS asset, NFC-1 First of pipeline of potential programs from CHOP collaboration Results of Phase 1 GREAT trial to be presented at American Academy of...
October 15, 2015 08:00 ET | Source: Medgenics, Inc.

Medgenics to Host Conference Call to Announce Third Quarter 2015 Results on October 22, 2015

PHILADELPHIA, Oct. 15, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE:MDGN) will host a conference call and live audio webcast on Thursday, October 22, 2015 at 8:30 a.m. ET to discuss third quarter...
October 13, 2015 08:00 ET | Source: Medgenics, Inc.

Medgenics Announces Key Appointments

PHILADELPHIA, Oct. 13, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN) today announced the following appointments: Liza Squires, MD joins as Vice President Research and Development,...
October 12, 2015 08:00 ET | Source: Medgenics, Inc.

Medgenics Announces Completion of Public Offering of Common Stock and Exercise in Full of Option to Purchase Additional Shares of Common Stock

PHILADELPHIA, Oct. 12, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN) today announced the completion of an underwritten public offering of 7,078,250 shares of its common stock, including...
October 01, 2015 09:01 ET | Source: Medgenics, Inc.

Medgenics Prices Public Offering of Common Stock

PHILADELPHIA, Oct. 1, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN) today announced the pricing of 6,155,000 shares of its common stock in a previously announced underwritten public...